Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Aethlon Medical (AEMD) over the last 14 years, with Q1 2025 value amounting to -$2192.0.

  • Aethlon Medical's Capital Expenditures fell 14467.09% to -$2192.0 in Q1 2025 from the same period last year, while for Dec 2024 it was $7099.0, marking a year-over-year decrease of 9724.04%. This contributed to the annual value of $250867.0 for FY2024, which is 7340.0% down from last year.
  • As of Q1 2025, Aethlon Medical's Capital Expenditures stood at -$2192.0, which was down 14467.09% from $2192.0 recorded in Q4 2024.
  • Aethlon Medical's 5-year Capital Expenditures high stood at $739165.0 for Q3 2022, and its period low was -$2192.0 during Q1 2025.
  • Over the past 5 years, Aethlon Medical's median Capital Expenditures value was $38374.0 (recorded in 2021), while the average stood at $103228.0.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 394490.57% in 2022, then crashed by 14467.09% in 2025.
  • Quarter analysis of 5 years shows Aethlon Medical's Capital Expenditures stood at $57934.0 in 2021, then skyrocketed by 161.48% to $151486.0 in 2022, then plummeted by 94.19% to $8807.0 in 2023, then tumbled by 75.11% to $2192.0 in 2024, then tumbled by 200.0% to -$2192.0 in 2025.
  • Its last three reported values are -$2192.0 in Q1 2025, $2192.0 for Q4 2024, and $4907.0 during Q1 2024.